Tuesday, November 5, 2024
HomeTagsNK

NK

Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation

Gilead Sciences, Inc. and Dragonfly Therapeutics announced a collaboration designed to advance a number of Dragonfly's novel natural killer (NK) cell engager-based immunotherapies for...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics